EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis and biological evaluation of Chidamide derivatives against breast cancer

Ying Zhou, Ziyan Lang, Haiyan Lin, Jian Wang, Boyu Zhang, Kadirya Asan, Xiujun Wang, Lu Sun, Jing Ji

Bioorganic & Medicinal Chemistry Letters · 2026-08 · 137 · 130652

DOI: 10.1016/j.bmcl.2026.130652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026-08. Verfasst von Ying Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China. Hauptthemen laut MEDLINE: Benzamides, Aminopyridines, Antineoplastic Agents, Drug Design. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we designed and synthesized a series of compounds derived from the histone deacetylase inhibitor (HDACi) Chidamide and the BET bromodomain inhibitor (+)-JQ-1. All target compounds were structurally characterized by 1H NMR, 13C NMR, and high-resolution mass spectrometry (HRMS). Antiproliferative activity was assessed by an MTT assay in MDA-MB-231 (breast cancer), HeLa (cervical cancer), and HCT116 (colon cancer) cells, with chidamide and (+)-JQ-1 as reference compounds; cytotoxicity in 293 T cells was further evaluated to estimate selectivity. Results indicated that most derivatives exhibited superior activity to Chidamide, with compound 6e demonstrating the strongest inhibitory effect against MDA-MB-231 cells. The IC50 values of 6e were 0.10 ± 0.02 μM (MDA-MB-231), 0.90 ± 0.17 μM (HeLa), 19.60 ± 0.90 μM (HCT116), and 70.13 ± 5.19 μM (293 T). Further assays showed that 6e inhibited colony formation, migration, adhesion, and invasion of MDA-MB-231 cells in a concentration-dependent manner. Annexin V-FITC/PI flow cytometry indicated apoptosis induction. In the chicken embryo chorioallantoic membrane (CAM) model, 6e inhibited tumor growth and angiogenesis more effectively than chidamide. In summary, 6e demonstrates promising optimization potential as a lead compound for breast cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzamidesAminopyridinesAntineoplastic AgentsDrug DesignBreast NeoplasmsHistone Deacetylase InhibitorsHumansCell ProliferationFemaleStructure-Activity RelationshipDrug Screening Assays, AntitumorAnimalsMolecular StructureCell Line, TumorMDA-MB-231 CellsDose-Response Relationship, DrugCell Movement

Stichwörter der Autor:innen

Antitumor activityBreast cancerChidamideDerivatives

Substanzen

N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamideBenzamidesAminopyridinesAntineoplastic AgentsHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China.
  • College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China. Electronic address: wangxiujun@jou.edu.cn.
  • College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou, Jiangsu 225300, PR China. Electronic address: youyouyoualterl@163.com.
  • College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou, Jiangsu 225300, PR China. Electronic address: jijing@jou.edu.cn.

Zitieren

APA

Zhou, Y., Lang, Z., Lin, H., Wang, J., Zhang, B., Asan, K., Wang, X., Sun, L., & Ji, J. (2026). Design, synthesis and biological evaluation of Chidamide derivatives against breast cancer. Bioorganic & Medicinal Chemistry Letters, 137, 130652. https://doi.org/10.1016/j.bmcl.2026.130652

Vancouver

Zhou Y, Lang Z, Lin H, Wang J, Zhang B, Asan K, et al. Design, synthesis and biological evaluation of Chidamide derivatives against breast cancer. Bioorganic & Medicinal Chemistry Letters. 2026;137:130652. doi:10.1016/j.bmcl.2026.130652

BibTeX
@article{Zhou2026,
  author = {Zhou, Ying and Lang, Ziyan and Lin, Haiyan and Wang, Jian and Zhang, Boyu and Asan, Kadirya and Wang, Xiujun and Sun, Lu and Ji, Jing},
  title = {Design, synthesis and biological evaluation of Chidamide derivatives against breast cancer},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2026},
  volume = {137},
  pages = {130652},
  doi = {10.1016/j.bmcl.2026.130652}
}
Kostenlos starten →